{'fraction_non_alphanumeric': 0.04969485614646905, 'fraction_numerical': 0.07497820401046207, 'mean_word_length': 4.683168316831683, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Response to clarifying the costs of conflicts of interest

beyond a culture of unexamined assumptions, recrimination, and blame to one of systematic analysis and ethical dialogue. Am J Bioeth 2011; 11: 31–3. 16 Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289: 454–65. 17 Lexchin J, Bero LA, Djulbegovic B et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167–70. 18 Neuman J, Korenstein D, Ross JS et al. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011; 343: d5621. 19 Yarborough M, Sharp RR. Public trust and research a decade later: what have we learned since Jesse Gelsinger’s death? Mol Genet Metab 2009; 97: 4–5. 20 Korn D, Carlat D. Conflicts of interest in medical education: recommendations from the pew task force on medical conflicts of interest. JAMA 2013; 310: 2397–8. 21 Resnik DB, Shamoo AE. Conflict of interest and the university. Account Res 2002; 9: 45–64.